The selective impairment of the TGF-β1 signaling pathway has been demonstrated in the early phase of AD pathogenesis [102] and this deficit of TGF-β1 contributes to neuroinflammation and cognitive decline in AD [103]. This evidence concerns the gene TGFB1 and Alzheimer disease.